My Question is… Networking Lunch Meeting
Registration is now closed. Please email email@example.com to be added to the waitlist.
Based on the success of our first ‘My Question is… Networking Lunch', we are excited to invite you to join us for our upcoming session allowing those meeting to gain new contacts or equally valuable engage with known contacts, as they maintain their networking during this challenging time.
We will be selecting up to six questions posed by our network and once selected those individuals will host small breakout groups to discuss that question, feeding back towards the end of the session. We welcome you suggestions for questions and they can be on any topic that you like. We'll try to select a good variety!
To submit your question, please email firstname.lastname@example.org.
You can also check out the blog post from our previous session here!
13.00 Arrive and welcome
13.10 Move to breakout rooms
Questions selected so far are:
Question 1: What should companies do to be more patient-centric both in terms of their discovery focus and development ambitions? [Mike Ward, DRG]
Question 2: Should patents be granted for COVID vaccine/therapy? [Tom Leanse, J A Kemp]
Question 3: What does sustainable investment look like in biotech? [Aline Charpentier, One Nucleus]
Question 4: What does it mean to be a "partner of choice" (and what can companies do to become one)? [Ann Dugdale, Taylors Hill Consulting]
Question 5: Should companies in the global industry be collaborating to generate infectious disease/ pandemic medicines? [John Faulkes, PPMLD]
Question 6: Finding targets for cell and gene therapy - what drives innovation and research? [Dawna Newcomb, Abcam]
13.40 Breakout rooms close and feedback session